IQVIA Holdings Inc.
Every calculator, already run for IQV
Open the full toolkit →You have the numbers on IQV. Get the argument.
A written report on which of these readings actually decide the outcome for IQVIA Holdings Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
21 analysts covering IQVAnalyst Price Target Disagreement for IQVIA Holdings Inc.
Wall Street's bull case implies +13% from the current price; the bear case implies -7%. Analysts are relatively aligned on IQV's range.
Ownership & short interest
Insider Trading Activity for IQV
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About IQVIA Holdings Inc.
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation cons…
IQV — frequently asked
Is IQV a buy right now?
Wall Street's consensus rating on IQVIA Holdings Inc. is Strong Buy across 21 analysts, with a mean price target of $277.94 (+4% vs. the current $266.42). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is IQV overvalued?
IQV trades at 33.1x trailing earnings, against a DCF fair value of $289 per share. The current price implies 5% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is IQV's next earnings date?
IQVIA Holdings Inc. is next scheduled to report earnings around Nov 3, 2026. A full IQV research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for IQVIA Holdings Inc.?
Analysts covering IQVIA Holdings Inc. (IQV) range from a bear-case target of $247.00 to a bull-case high of $300.00, with a mean consensus target of $277.94 across 18 analysts. The spread of $53.00 (20% of the current price) indicates moderate disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare IQVIA Holdings Inc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For IQVIA Holdings Inc.
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full IQV research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on IQVIA Holdings Inc., in minutes. 3 free reports included with every account — no credit card required.